Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Microb Pathog ; 124: 47-53, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30118805

ABSTRACT

PURPOSE: In this study, we aimed to investigate biofilm formation characteristics in clinical Staphylococcus aureus (S. aureus) isolates with erythromycin (ERY) resistance from China and further analyze their correlations with antimicrobial susceptibility and molecular characteristics. METHODOLOGY: A total of 276 clinical isolates of ERY-resistant S. aureus, including 142 methicillin-resistant S. aureus (MRSA) strains and 134 methicillin-susceptible S. aureus (MSSA) strains, were retrospectively collected in China. Biofilms were determined by crystal violet staining and ERY resistance genes (ermA, ermB and ermC) were detected by polymerase chain reaction. Inducible clindamycin resistance was examined by D test and multilocus sequence typing, and clonal complexes (CCs) based on housekeeping genes were further determined. RESULTS: The frequency of biofilm formation among ERY-resistant S. aureus was 40.9% (113/276) in total and no significant difference was found for the frequency of biofilm formation between ERY-resistant MRSA and ERY-resistant MSSA (44.4% vs 37.3%, P > 0.05). In ERY-resistant MRSA isolates, the frequency of biofilm formation in ermA-positive, gentamicin-resistant and ciprofloxacin-resistant isolates was higher than that in ermA-negative, gentamicin-sensitive and ciprofloxacin-sensitive isolates, respectively (63.9% vs 23.6%, P < 0.01; 60.3% vs 27.5%, P < 0.01; 65.2% vs 26.3%, P < 0.01). In addition, tetracycline resistance facilitated biofilm formation in both ERY-resistant MRSA and MSSA and the frequency of biofilm formation in CC239- or CC7S. aureus isolates with ERY resistance was significantly higher compared with that in CC59S. aureus (both P < 0.01). CONCLUSION: The ermA gene, and gentamicin, ciprofloxacin and tetracycline resistance facilitate biofilm formation in ERY-resistant MRSA isolates and, moreover, ERY-resistant S. aureus isolates with positive biofilm formation exhibited clonality clustering regarding CC239 and CC7.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/growth & development , Drug Resistance, Bacterial , Erythromycin/pharmacology , Genotype , Staphylococcus aureus/physiology , China , Disk Diffusion Antimicrobial Tests , Genes, Essential , Hospitals, University , Humans , Multilocus Sequence Typing , Polymerase Chain Reaction , Retrospective Studies , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Transcriptional Activation/drug effects , tRNA Methyltransferases/genetics
2.
Curr Microbiol ; 73(3): 361-365, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27246497

ABSTRACT

Enteropathogenic Escherichia coli (EPEC) is a major cause of infantile diarrhea in developing countries. The translocator EspB is a key virulence factor in the process of the attaching and effacing effect of EPEC and plays a critical role in the pathogenesis of the bacteria. In this study, we aimed to select the peptides binding to EspB protein by phage display library and further investigate whether these peptides can decrease the extent of invasion and virulence of EPEC on host cells by targeting to EspB protein. The expression and purification of EspB protein from E. coli was demonstrated by Western blotting. The Ph.D. 12-mer peptide phage display library was used to screen the candidate peptides binding specifically to EspB protein. Furthermore, the affinity of these candidate peptides bound to EspB was identified by enzyme-linked immunosorbent assay (ELISA). Moreover, we investigated whether these screened peptides could decrease the adherence ratio of EPEC to HEp-2 cells with increasing concentration. Successful purification of EspB protein from pET21b-EspB-transformed E. coli was identified by Western blotting. Then, the candidate peptides including phages 6, 7, 8, and 12 were screened by the Ph.D. 12-mer peptide phage display library and ELISA test demonstrated that their affinity binding to EspB protein was high compared with the control. Functional analysis indicated that synthetic peptide-6 (YFPYSHTSPRQP) significantly decreased the adherence ratio of EPEC to HEp-2 cells with increasing concentration (P < 0.01). Peptide-6 (100 µg/mL) could lead to a 40 % decrease in the adherence ratio of EPEC to HEp-2 cells compared with control (P < 0.01). However, the other three peptides at different concentrations showed only a slight ability to block the adherence of EPEC to host cells. Our data provided a potential strategy to inhibit the adhesion of EPEC to epithelial cells by a candidate peptide targeted toward EspB protein.


Subject(s)
Bacterial Adhesion/drug effects , Bacterial Outer Membrane Proteins/antagonists & inhibitors , Enteropathogenic Escherichia coli/physiology , Epithelial Cells/microbiology , Escherichia coli Infections/microbiology , Escherichia coli Proteins/antagonists & inhibitors , Peptides/pharmacology , Amino Acid Sequence , Bacterial Outer Membrane Proteins/genetics , Bacterial Outer Membrane Proteins/metabolism , Enteropathogenic Escherichia coli/drug effects , Enteropathogenic Escherichia coli/genetics , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Hep G2 Cells , Humans , Molecular Sequence Data , Peptides/chemistry
3.
Curr Microbiol ; 73(4): 498-502, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27344596

ABSTRACT

Staphylococcus aureus is a well-known organism which is responsible for a variety of human infectious diseases including skin infections, pneumonia, bacteremia, and endocarditis. Few of the microorganisms can be transmitted from mother to the newborn or infant by milk breastfeeding. This study aims to identify transmission of S. aureus from healthy, lactating mothers to their infants by breastfeeding. Stool specimens of diarrheal infants and breast milk of their mother (totally three pairs) were collected and six Staphylococcus aureus isolates were cultured positively. Homology and molecular characters of isolated strains were tested using pulsed-field gel electrophoresis (PFGE), spa typing, and multilocus sequence typing. Furthermore, toxin genes detection was also performed. Each pair of isolates has the same PFGE type and spa type. Four Sequence types (STs) were found among all the isolates; they are ST15, ST188, and ST59, respectively. Among the strains, seb, sec, and tst genes were found, and all were negative for pvl gene. The homology of the S. aureus strains isolated from the infants' stool and the mothers' milk was genetically demonstrated, which indicated that breastfeeding may be important in the transmission of S. aureus infection, and the character of S. aureus needed to be further evaluated.


Subject(s)
Diarrhea, Infantile/microbiology , Milk, Human/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/physiology , Adult , Breast Feeding/adverse effects , China , Diarrhea, Infantile/etiology , Feces/microbiology , Female , Humans , Infant , Infant, Newborn , Infectious Disease Transmission, Vertical , Male , Multilocus Sequence Typing , Staphylococcal Infections/etiology , Staphylococcal Infections/transmission , Staphylococcus aureus/classification , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Young Adult
4.
Int J Infect Dis ; 33: 32-6, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25546169

ABSTRACT

OBJECTIVES: Sucrose gel was used to treat bacterial vaginosis in a phase III clinical trial. However, the changes of vaginal flora after treatment were only examined by Nugent score in that clinical trial, While the vaginal microbiota of rhesus macaques is characterized by anaerobic, Gram-negative bacteria, few lactobacilli, and pH levels above 4.6, similar to the microbiota of patients with bacterial vaginosis. This study is aimed to investigate the change of the vaginal microbiota of rehsus macaques after topical use of sucrose gel to reveal more precisely the bacterial population shift after the topical application of sucrose gel. METHODS: Sixteen rhesus macaques were treated with 0.5 g sucrose gel vaginally and three with 0.5 g of placebo gel. Vaginal swabs were collected daily following treatment. Vaginal pH levels and Nugent scores were recorded. The composition of the vaginal micotbiota was tested by V3∼V4 16S rDNA metagenomic sequencing. Dynamic changes in the Lactobacillus genus were analyzed by qPCR. RESULTS: The vaginal microbiota of rhesus macaques are dominated by anaerobic Gram-negative bacteria, with few lactobacilli and high pH levels above 4.6. After five days' treatment with topical sucrose gel, the component percentage of Lactobacillus in vaginal microbiota increased from 1.31% to 81.59%, while the component percentage of Porphyromonas decreased from 18.60% to 0.43%, Sneathia decreased from 15.09% to 0.89%, Mobiluncus decreased from 8.23% to 0.12%, etc.. The average vaginal pH values of 16 rhesus macaques of the sucrose gel group decreased from 5.4 to 3.89. There were no significant changes in microbiota and vaginal pH observed in the placebo group. CONCLUSIONS: Rhesus macaques can be used as animal models of bacterial vaginosis to develop drugs and test treatment efficacy. Furthermore, the topical application of sucrose gel induced the shifting of vaginal flora of rhesus macaques from a BV kind of flora to a lactobacilli-dominating flora.


Subject(s)
Microbiota , Sucrose/administration & dosage , Vagina/microbiology , Vaginosis, Bacterial/microbiology , Administration, Topical , Animals , Female , Gram-Negative Bacteria/genetics , Gram-Negative Bacteria/isolation & purification , Humans , Lactobacillus/genetics , Lactobacillus/isolation & purification , Macaca mulatta , Sucrose/therapeutic use , Vaginosis, Bacterial/drug therapy
5.
Int J Infect Dis ; 30: 49-51, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25236388

ABSTRACT

OBJECTIVE: It has been reported that LZD-resistant Enterococcus in the gastrointestinal tract of mice colonizes persistently and shows variable minimum inhibitor concentration (MIC) values. However, the colonization characteristics of Enterococcus with LZD resistance in patients remain elusive. Here, we report the case of a patient with recurrent pneumonia due to infection with LZD-resistant Enterococcus faecalis strains. The colonization characteristics of the strains isolated from this patient were analyzed. METHODS: Ten E. faecalis strains were isolated from tracheal secretions obtained from the patient during five recurrences of pneumonia over the course of 10 months. Clonal relationships were determined by pulsed-field gel electrophoresis (PFGE) with SmaI-macrorestricted genomic DNA. The susceptibility of the isolates to LZD was determined by Etest in Mueller-Hinton agar. RESULTS: The homology of these strains was demonstrated by PFGE, suggesting that occult bacterial colonization by LZD-resistant E. faecalis is possible as late as a year after exposure to LZD. These strains showed variable MICs as determined by the Etest. LZD-resistant isolates contained single or double nucleotide mutations in domain V of 23S rRNA as confirmed by PCR and sequencing. The sensitivity of the strains to vancomycin was demonstrated by broth macrodilution, and vancomycin was an effective clinical treatment on each occasion. CONCLUSIONS: Our results indicate that LZD-resistant E. faecalis strains may colonize persistently in vivo, leading to recurrent infection.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Enterococcus faecalis/drug effects , Gram-Positive Bacterial Infections/microbiology , Linezolid/therapeutic use , Pneumonia, Bacterial/microbiology , Drug Resistance, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Enterococcus faecalis/genetics , Enterococcus faecalis/isolation & purification , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Humans , Male , Middle Aged , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/drug therapy , Recurrence , Vancomycin/therapeutic use , Vancomycin Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...